1. Home
  2. ASMB vs SQNS Comparison

ASMB vs SQNS Comparison

Compare ASMB & SQNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$35.36

Market Cap

512.1M

Sector

Health Care

ML Signal

HOLD

Logo Sequans Communications S.A.

SQNS

Sequans Communications S.A.

HOLD

Current Price

$2.87

Market Cap

46.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASMB
SQNS
Founded
2005
2003
Country
United States
France
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
512.1M
46.9M
IPO Year
2010
2011

Fundamental Metrics

Financial Performance
Metric
ASMB
SQNS
Price
$35.36
$2.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$44.20
$20.33
AVG Volume (30 Days)
289.7K
29.5K
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
91.78
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$638.39
$49.79
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.23
$2.38
52 Week High
$39.71
$10.93

Technical Indicators

Market Signals
Indicator
ASMB
SQNS
Relative Strength Index (RSI) 61.60 47.12
Support Level $32.57 $2.72
Resistance Level $37.00 $3.20
Average True Range (ATR) 1.56 0.12
MACD 0.02 -0.01
Stochastic Oscillator 62.11 23.60

Price Performance

Historical Comparison
ASMB
SQNS

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

About SQNS Sequans Communications S.A.

Sequans Communications SA is a fabless semiconductor company specializing in wireless 4G and 5G cellular technologies for the Internet of Things (IoT). Sequans' engineers design and develop, secure, and energy-efficient semiconductor solutions that enable the next generation of AI-connected applications, including smart energy metering, industrial automation, smart mobility and logistics, secure payments, e-health, and smart home solutions. The Company offers a comprehensive portfolio of wireless connectivity solutions, including radio frequency (RF) transceivers, integrated circuits (ICs) for baseband processing, as well as modules, software, & protocol stacks. The Company has one operating segment, which is the design & marketing of semiconductor components for cellular wireless systems.

Share on Social Networks: